Chronic HCV infection is a global health problem that affects> 184 million people worldwide.
HCV is associated with several hepatic and extrahepatic disorders, including several …

To survey the burden of liver disease in Europe and its causes 260 epidemiological studies
published in the last five years were reviewed. The incidence and prevalence of cirrhosis …

Background Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in
this paper) are a major cause of morbidity and mortality globally, although the burden and …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Background Liver cirrhosis is a major yet largely preventable and underappreciated cause
of global health loss. Variations in cirrhosis mortality at the country level reflect differences in …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

The decline of immunization rates in countries of origin of migrants and refugees, along with
risky conditions during the journey to Europe, may threaten migrants' health. We performed …

The last 50 years of hepatitis B research has resulted in the development of effective
screening assays for surveillance, vaccines for prevention and antiviral drugs that …

Patients with chronic HBV infection are at risk of reactivation of HBV should they require
immunosuppressive therapies for a variety of clinical settings, including chemotherapy for …